Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. MDxHealth SA
  6. Summary
    MDXH   BE0003844611

MDXHEALTH SA

(MDXH)
  Report
Real-time Euronext Bruxelles  -  11:35:15 2023-02-01 am EST
0.6380 EUR   +1.43%
12:31aMDxHealth Kicks Off $40 Million Offering of American Depositary Shares
MT
02/01MDxHealth Announces Launch of Offering of ADSs in the United States
GL
02/01MDxHealth Announces Launch of Offering of ADSs in the United States
GL
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
01/26/2023 01/27/2023 01/30/2023 01/31/2023 02/01/2023 Date
0.634(c) 0.646(c) 0.63(c) 0.629(c) 0.638(c) Last
22 408 18 413 11 942 16 241 25 205 Volume
+0.16% +1.89% -2.48% -0.16% +1.43% Change
More quotes
Estimated financial data (e)
Sales 2022 34,6 M 37,8 M 37,8 M
Net income 2022 -37,5 M -41,0 M -41,0 M
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Sales 2023 61,8 M 67,5 M 67,5 M
Net income 2023 -26,8 M -29,3 M -29,3 M
Net Debt 2023 - - -
P/E ratio 2023 -
Yield 2023 -
Capitalization 104 M 113 M 113 M
Capi. / Sales 2022 3,01x
Capi. / Sales 2023 1,68x
Nbr of Employees 191
Free-Float 84,3%
More Financials
Company
MDxHealth SA, leader in molecular diagnostics, is a company that develops and commercializes advanced epigenetic assays and service testing for cancer assessment and the personalized treatment of patients. The activity is organized around two product families: - epigenetic molecular tests (ConfirmMDx): useful and innovative tests that allow researchers to correctly identify prostate cancer and treat it; -... 
Read more
Sector
Biotechnology & Medical Research
Calendar
03/01 | 04:00pmEarnings Release
More about the company
All news about MDXHEALTH SA
12:31aMDxHealth Kicks Off $40 Million Offering of American Depositary Shares
MT
02/01MDxHealth Announces Launch of Offering of ADSs in the United States
GL
02/01MDxHealth Announces Launch of Offering of ADSs in the United States
GL
01/20MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisitio..
GL
01/20MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisitio..
AQ
01/09MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
GL
01/09MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
AQ
01/09MDxHealth SA Provides Revenue Guidance for the Year 2022 and Reaffirms Revenue Guidance..
CI
2022Weak Investors Sentiment Weighs on American Depositary Receipts of European Equities
MT
2022Mdxhealth files U.S. Shelf Registration on Form F-3
GL
2022Mdxhealth files U.S. Shelf Registration on Form F-3
AQ
2022Mdxhealth : Report of Independent Auditors - Form 6-K
PU
2022MDxHealth Provides Business Update
GL
2022MDxHealth Provides Business Update
GL
2022MDxHealth SA Provides Revenue Guidance for the Fiscal Year 2023
CI
More news
News in other languages on MDXHEALTH SA
01:54aBel20 in het groen van start na rentebesluit Fed
01:08aMDxHealth verkoopt voor 40 miljoen dollar aan Amerikaanse aandelen
12:31aMDxHealth donne le coup d'envoi d'un placement de 40 millions de dollars d'American Dep..
02/01MDxHealth annonce le lancement d'une offre  d'ADSs aux États-Unis
01/30Bijna alle aandelen Bel20 in het rood
More news
Analyst Recommendations on MDXHEALTH SA
More recommendations
Chart MDXHEALTH SA
Duration : Period :
MDxHealth SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MDXHEALTH SA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 0,64
Average target price
Spread / Average Target -
Managers and Directors
Michael K. McGarrity Chief Executive Officer & Executive Director
Ron Kalfus Chief Financial Officer
Koen Hoffman Chairman
Miriam Reyes Executive Vice President-Operations
Joseph Sollee Chief Compliance Officer, EVP & General Counsel
Sector and Competitors
1st jan.Capi. (M$)
MDXHEALTH SA6.69%113
MODERNA, INC.-2.96%66 963
IQVIA HOLDINGS INC.13.96%43 368
LONZA GROUP AG14.99%42 273
ALNYLAM PHARMACEUTICALS, INC.-4.73%27 670
SEAGEN INC.8.19%25 813